Cat. No. |
Product Name |
Effect
|
Purity |
Rare Diseases
|
HY-101502A |
SB290157 trifluoroacetate |
Antagonist |
99.87% |
Unkown |
HY-12481 |
SAR405 |
Inhibitor |
99.49% |
Unkown |
HY-N0376 |
Liquiritin |
|
99.68% |
Unkown |
HY-138161 |
JR14a |
Antagonist |
99.59% |
Unkown |
HY-P1036 |
Compstatin |
Inhibitor |
99.76% |
Unkown |
HY-132295 |
Azenosertib |
Inhibitor |
99.96% |
Unkown |
HY-Y0479AS |
L-Lactic acid-13C3 sodium |
|
≥98.0% |
Unkown |
HY-15976 |
P7C3 |
|
99.85% |
Unkown |
HY-103007 |
TC-G-1008 |
Agonist |
99.61% |
Unkown |
HY-15978 |
P7C3-A20 |
|
98.97% |
Unkown |
HY-125877 |
PROTAC Mcl1 degrader-1 |
Inhibitor |
98.13% |
Unkown |
HY-128358 |
MR-L2 |
Activator |
99.23% |
Unkown |
HY-P2848 |
Cholesterol oxidase, Microorganism |
|
≥90.0% |
Unkown |
HY-108568 |
15-Deoxy-Δ-12,14-prostaglandin J2 |
Agonist |
≥99.0% |
Unkown |
HY-112633 |
SMN-C3 |
Modulator |
99.89% |
Unkown |
HY-Y0479S |
L-Lactic acid-13C3 |
|
99.10% |
Unkown |
HY-128132 |
C3a receptor agonist 1 |
Agonist |
98.04% |
Unkown |
HY-P1345A |
TLQP-21 TFA |
Agonist |
99.90% |
Unkown |
HY-W015913S |
Sodium 2-oxopropanoate-13C3 |
Inhibitor |
99.7% |
Unkown |
HY-138557 |
AKR1C3-IN-4 |
Inhibitor |
99.77% |
Unkown |
HY-N6978 |
Ascr#5 |
|
≥98.0% |
Unkown |
HY-147090 |
Tazemetostat de(methylene morpholine)-O-C3-O-C-COOH |
Degrader |
98.24% |
Unkown |
HY-161022A |
FL118-C3-O-C-amide-C-NH2 formate |
|
95.82% |
Unkown |
HY-N0650S |
L-Serine-13C3 |
|
98.20% |
Unkown |
HY-Y0337S |
L-Cysteine-13C3,15N |
|
99.9% |
Unkown |
HY-150644 |
S07-2010 |
Inhibitor |
99.79% |
Unkown |
HY-107379 |
AKR1C3-IN-1 |
Inhibitor |
98.23% |
Unkown |
HY-126521 |
N3-C3-NHS ester |
|
99.46% |
Unkown |
HY-B1337S4 |
Choline Chloride-13C3 |
|
99.69% |
Unkown |
HY-133479 |
Tetrazine-Ph-NHCO-C3-NHS ester |
|
98.28% |
Unkown |
HY-P3252A |
Pegcetacoplan acetate |
Inhibitor |
98.72% |
Unkown |
HY-130142A |
Biotinyl-NH-PEG3-C3-amido-C3-COOH |
|
99.91% |
Unkown |
HY-140902A |
Biotin-PEG3-C3-NH2 |
|
≥97.0% |
Unkown |
HY-N10361 |
Drupanin |
|
98.05% |
Unkown |
HY-103612 |
Thalidomide-O-amido-C3-COOH |
Inducer |
98.43% |
Unkown |
HY-162266 |
C3TD879 |
Inhibitor |
99.42% |
Unkown |
HY-N1981S |
Triolein-13C3 |
Inhibitor |
98.00% |
Unkown |
HY-145127 |
ETZ |
|
97.06% |
Unkown |
HY-155035 |
S07-1066 |
Inhibitor |
99.48% |
Unkown |
HY-D1342 |
Coumberol |
|
99.99% |
Unkown |
HY-W422359A |
2-Aminopurine-O-Ph-NHCO-C3-COOH hydrochloride |
|
95.27% |
Unkown |
HY-131185 |
Pomalidomide-amido-C3-COOH |
|
99.51% |
Unkown |
HY-100683 |
A12B4C3 |
Inhibitor |
98.0% |
Unkown |
HY-113128S |
sn-Glycerol 3-phosphate-13C3 disodium |
|
98.7% |
Unkown |
HY-133618 |
Pomalidomide-C3-adavosertib |
Degrader |
99.84% |
Unkown |
HY-135306 |
Cl-C6-PEG4-C3-COOH |
|
99.65% |
Unkown |
HY-152189 |
S19-1035 |
|
99.77% |
Unkown |
HY-N0650S5 |
L-Serine-13C3,15N |
|
≥99.0% |
Unkown |
HY-W004701 |
Br-C3-methyl ester |
|
98.61% |
Unkown |
HY-Y0337S4 |
L-Cysteine-13C3 |
|
99.90% |
Unkown |
HY-103608 |
(S,R,S)-AHPC-(C3-PEG)2-C6-Cl |
|
99.89% |
Unkown |
HY-108568S |
15-Deoxy-Δ-12,14-prostaglandin J2-d4 |
Agonist |
98.10% |
Unkown |
HY-117992 |
BR103 |
|
99.75% |
Unkown |
HY-130711B |
(S,R,S)-AHPC-C3-NH2 hydrochloride |
|
96.38% |
Unkown |
HY-B1659S5 |
Glycerol-13C3 |
|
99.10% |
Unkown |
HY-N0322S4 |
Cholesterol-13C3 |
Agonist |
98.8% |
Unkown |
HY-N0680S3 |
Thiamine-13C3 hydrochloride |
|
99.90% |
Unkown |
HY-P1505A |
C3a (70-77) (TFA) |
|
95.02% |
Unkown |
HY-12481A |
SAR405 R enantiomer |
|
99.94% |
Unkown |
HY-145225 |
DLin-K-C3-DMA |
Chemical |
≥98.0% |
Unkown |
HY-128856 |
P7C3-OMe |
|
98.26% |
Unkown |
HY-140928 |
Biotin-PEG4-amino-t-Bu-DADPS-C3-alykne |
|
≥95.0% |
Unkown |
HY-152188 |
AKR1C3-IN-9 |
Inhibitor |
99.37% |
Unkown |
HY-161022S1 |
FL118-C3-O-C-amide-C-NH2-d5 formate |
|
/ |
Unkown |
HY-B1342S3 |
Retinol-13C3 |
|
95.71% |
Unkown |
HY-N0136S1 |
(±)-Taxifolin-13C3 |
Inhibitor |
99.63% |
Unkown |
HY-R00006 |
hsa-let-7c-3p mimic |
|
93.63% |
Unkown |
HY-R00717 |
hsa-miR-34c-3p mimic |
|
94.18% |
Unkown |
HY-R01568 |
hsa-miR-518c-3p mimic |
|
92.33% |
Unkown |
HY-R01678 |
hsa-miR-548c-3p mimic |
|
92.16% |
Unkown |
HY-RI00407 |
hsa-miR-200c-3p inhibitor |
|
94.62% |
Unkown |
HY-W004640 |
N-Boc-C1-PEG3-C3-NH2 |
|
≥98.0% |
Unkown |
HY-115560A |
Thalidomide-O-amido-C3-NH2 TFA |
Inducer |
99.58% |
Unkown |
HY-131646 |
Thalidomide-O-amido-C3-PEG3-C1-NH2 |
Inducer |
99.08% |
Unkown |
HY-109154 |
Obafistat |
Inhibitor |
99.92% |
Unkown |
HY-P1036A |
Compstatin TFA |
Inhibitor |
99.02% |
Unkown |
HY-100196S1 |
Pyrroloquinoline quinone-13C3 sodium |
|
99.29% |
Unkown |
HY-113008AS |
cis-Urocanic acid-13C3 |
Agonist |
99.46% |
Unkown |
HY-120903 |
DBCO-C3-Acid |
|
≥95.0% |
Unkown |
HY-131455A |
Biotin-C1-PEG3-C3-amido-C5-Gly-Arg-Gly-N3 TFA |
|
≥98.0% |
Unkown |
HY-131888 |
Pomalidomide-C3-NH2 hydrochloride |
|
95.38% |
Unkown |
HY-138847A |
Thalidomide-4-O-C3-NH2 hydrochloride |
Inducer |
/ |
Unkown |
HY-144432S |
Vitamin B5-13C3,15N hemicalcium hemihydrate |
|
99.7% |
Unkown |
HY-148142 |
Pomalidomide-C3-NHS ester |
|
/ |
Unkown |
HY-150156 |
Anti-inflammatory agent 32 |
|
99.52% |
Unkown |
HY-15129S |
O-Phospho-L-serine-13C3,15N |
Modulator |
99.19% |
Unkown |
HY-158118 |
Lys(CO-C3-p-I-Ph)-OMe |
|
97.19% |
Unkown |
HY-158122 |
Lys(CO-C3-p-I-Ph)-O-tBu |
|
98.14% |
Unkown |
HY-160897 |
Methoxy-PEG-C3-amide-C2-Mal |
|
99.69% |
Unkown |
HY-161022 |
FL118-C3-O-C-amide-C-NH2 |
|
/ |
Unkown |
HY-161022S |
FL118-C3-O-C-amide-C-NH2-d5 |
|
/ |
Unkown |
HY-40354S |
Tofacitinib-13C3 |
|
/ |
Unkown |
HY-B1773AS3 |
Propanoic-13C3 sodium |
|
/ |
Unkown |
HY-D1056C1 |
Lipopolysaccharides, from S. enterica serotype enteritidis |
Activator |
/ |
Unkown |
HY-N0437S2 |
Progesterone-13C3 |
Agonist |
99.60% |
Unkown |
HY-N0898S |
Catechin-13C3 |
|
98.06% |
Unkown |
HY-N2362S1 |
DL-Alanine-13C-3 |
|
≥98.0% |
Unkown |
HY-N4134 |
Ciwujianoside C3 |
Inhibitor |
≥98.0% |
Unkown |
HY-R00840 |
hsa-miR-376c-3p mimic |
|
/ |
Unkown |
HY-RI00840 |
hsa-miR-376c-3p inhibitor |
|
/ |
Unkown |
HY-W010407S |
Cyanuric acid-13C3 |
|
≥98.0% |
Unkown |
HY-W010421S |
Ammelide-13C3 |
|
99.85% |
Unkown |
HY-B0356AS1 |
Ciprofloxacin-13C3,15N monohydrochloride |
|
99.9% |
Unkown |
HY-W392808 |
Spacer phosphoramidite C3 |
|
≥98.0% |
Unkown |
HY-115560 |
Thalidomide-O-amido-C3-NH2 |
Inducer |
/ |
Unkown |
HY-130711A |
(S,R,S)-AHPC-C3-NH2 TFA |
|
/ |
Unkown |
HY-131876 |
Thalidomide-O-C3-acid |
Inducer |
/ |
Unkown |
HY-135900 |
Aniline-MPB-amino-C3-PBD |
Inhibitor |
/ |
Unkown |
HY-130711 |
(S,R,S)-AHPC-C3-NH2 |
|
/ |
Unkown |
HY-131186 |
Pomalidomide-amido-C3-piperazine-N-Boc |
|
/ |
Unkown |
HY-111297 |
BMVC4 |
|
/ |
Unkown |
HY-111843 |
Ch55-O-C3-NH2 |
|
/ |
Unkown |
HY-112251S |
D-Lin-MC3-DMA-13C3 |
|
/ |
Unkown |
HY-113008S1 |
Urocanic acid-13C3 |
|
/ |
Unkown |
HY-113357S |
m-Coumaric acid-13C3 |
|
/ |
Unkown |
HY-114773 |
N-Undecanoyl-L-homoserine lactone |
|
/ |
Unkown |
HY-115902 |
FGFR4-IN-7 |
|
/ |
Unkown |
HY-116021S |
Buquinolate-13C3 |
Inhibitor |
/ |
Unkown |
HY-116025 |
APN-C3-PEG4-alkyne |
|
/ |
Unkown |
HY-116084S1 |
Trimethylamine-N-oxide-13C3 |
Activator |
/ |
Unkown |
HY-117074 |
BMS-247243 |
|
/ |
Unkown |
HY-121412 |
Lankacidin C |
Inhibitor |
/ |
Unkown |
HY-121635 |
FOX-7 |
|
/ |
Unkown |
HY-12210 |
(S)-BI-1001 |
Inhibitor |
/ |
Unkown |
HY-12542S |
Dantrolene-13C3 |
Inhibitor |
≥99.0% |
Unkown |
HY-126287 |
JND4135 |
|
/ |
Unkown |
HY-128748S4 |
DL-Glyceraldehyde-13C3 |
|
/ |
Unkown |
HY-128753S4 |
D-Lyxose-13C-3 |
|
/ |
Unkown |
HY-130142 |
Biotinyl-NH-PEG3-C3-amido-C3-COOH (DIPEA) |
|
/ |
Unkown |
HY-130585S |
Estradiol undecylate-13C3 |
|
/ |
Unkown |
HY-130711C |
(S,R,S)-AHPC-C3-NH2 dihydrochloride |
|
/ |
Unkown |
HY-131184 |
N-Boc-piperazine-C3-COOH |
|
/ |
Unkown |
HY-131190 |
N-Boc-SBP-0636457-O-C3-COOH |
|
/ |
Unkown |
HY-131888A |
Pomalidomide-C3-NH2 |
|
/ |
Unkown |
HY-133403A |
Biotin-C1-PEG3-C3-amine TFA |
|
/ |
Unkown |
HY-133584 |
Bis-SS-C3-NHS ester |
|
/ |
Unkown |
HY-133585 |
Bis-SS-C3-sulfo-NHS ester |
|
/ |
Unkown |
HY-133702 |
Aniline-piperazine-C3-NH-Boc |
|
/ |
Unkown |
HY-134679 |
N-Boc-C1-PEG5-C3-NH2 |
|
/ |
Unkown |
HY-134692 |
Azido-C1-PEG3-C3-NH2 |
|
/ |
Unkown |
HY-134693 |
Azido-C1-PEG4-C3-NH2 |
|
/ |
Unkown |
HY-134749 |
Propargyl-PEG2-urea-C3-triethoxysilane |
|
/ |
Unkown |
HY-135901 |
Py-MPB-amino-C3-PBD |
Inhibitor |
/ |
Unkown |
HY-13632S1 |
Exemestane-13C3 |
Inhibitor |
/ |
Unkown |
HY-136457S |
2-NP-AHD-13C3 |
|
/ |
Unkown |
HY-13653S |
(+/-)-Epigallocatechin Gallate-13C3 |
|
/ |
Unkown |
HY-138847 |
Thalidomide-O-C3-NH2 |
Inducer |
/ |
Unkown |
HY-138850 |
Thalidomide-NH-amido-C3-NH2 |
Inducer |
/ |
Unkown |
HY-138850A |
Thalidomide-NH-amido-C3-NH2 hydrochloride |
Inducer |
/ |
Unkown |
HY-139145S |
Etbicyphat-13C3 |
|
/ |
Unkown |
HY-139427S |
3-Methylglutaconic acid-13C3 |
|
/ |
Unkown |
HY-139545 |
Thalidomide-4-C3-NH2 hydrochloride |
Inducer |
/ |
Unkown |
HY-139721 |
Tenofovir-C3-O-C15-CF3 ammonium |
Inhibitor |
/ |
Unkown |
HY-139722 |
Tenofovir-C3-O-C12-trimethylsilylacetylene ammonium |
Inhibitor |
/ |
Unkown |
HY-140019 |
Azido-PEG3-amide-C3-triethoxysilane |
|
/ |
Unkown |
HY-140288 |
DBCO-C3-PEG4-amine |
|
/ |
Unkown |
HY-140295 |
DBCO-C3-PEG4-NH-Boc |
|
/ |
Unkown |
HY-140347 |
APN-C3-NH-Boc |
|
/ |
Unkown |
HY-140478 |
Boc-NH-PEG4-C3-acid |
|
/ |
Unkown |
HY-140808 |
Azido-PEG3-C3-OH |
|
/ |
Unkown |
HY-140841 |
APN-C3-PEG4-azide |
|
98.56% |
Unkown |
HY-140902 |
rel-Biotin-PEG3-C3-NH2 |
|
/ |
Unkown |
HY-140927 |
Azido-C3-UV-biotin |
|
/ |
Unkown |
HY-141065 |
N-(azide-PEG3)-N'-(Amine-C3-Amide-PEG4)-Cy5 |
|
/ |
Unkown |
HY-141407 |
m-PEG3-amido-C3-triethoxysilane |
|
/ |
Unkown |
HY-141597 |
Acid-C3-SSPy |
|
/ |
Unkown |
HY-141651 |
(S,R,S)-AHPC-C3-COOH |
|
/ |
Unkown |
HY-141857S |
5-(4-Hydroxyphenyl)-5-phenyl-d5-hydantoin-2,4,5-13C3 |
|
/ |
Unkown |
HY-141893 |
3-Cyanovinylcarbazole phosphoramidite |
Inhibitor |
/ |
Unkown |
HY-141901S2 |
Dehydroepiandrosterone-13C3 |
|
/ |
Unkown |
HY-141907S |
17β-Estradiol-13C3 |
|
/ |
Unkown |
HY-142140S |
3-epi-25-Hydroxy Vitamin D3-d6 |
|
/ |
Unkown |
HY-143342 |
LEB-03-144 |
|
/ |
Unkown |
HY-143400 |
HSP70-IN-3 |
Inhibitor |
/ |
Unkown |
HY-143439 |
LX-039 |
Antagonist |
/ |
Unkown |
HY-144749 |
AKR1C3-IN-5 |
|
/ |
Unkown |
HY-145253 |
Tri(TLR4-IN-C34-C2-amide-PEG1)-amide-C3-COOH |
Inhibitor |
/ |
Unkown |
HY-145254 |
Tri(TLR4-IN-C34-PEG2-amide-PEG1)-amide-C3-COOH |
Inhibitor |
/ |
Unkown |
HY-145255 |
Tri(TLR4-IN-C34-C2-amide-C3-amide-PEG1)-amide-C3-COOH |
Inhibitor |
/ |
Unkown |
HY-14605S |
Rasagiline-13C3 mesylate |
|
/ |
Unkown |
HY-146573 |
AKR1C3-IN-6 |
Inhibitor |
/ |
Unkown |
HY-146574 |
AKR1C3-IN-7 |
Inhibitor |
/ |
Unkown |
HY-146575 |
AKR1C3-IN-8 |
Inhibitor |
/ |
Unkown |
HY-148460 |
Mal-VC-PAB-(N-Me-amide-C3)-ADU-S100 triethylamine |
|
/ |
Unkown |
HY-148471A |
C3-Amide-C4-NH2 |
|
/ |
Unkown |
HY-149749 |
Methylthiomcresol-C3-COOH |
|
/ |
Unkown |
HY-150624 |
SARS-CoV-2 nsp13-IN-3 |
Inhibitor |
/ |
Unkown |
HY-150646 |
S07-2009 |
|
/ |
Unkown |
HY-150648 |
S07-2008 |
Inhibitor |
/ |
Unkown |
HY-150649 |
S07-2005 (racemic) |
|
/ |
Unkown |
HY-150650 |
S07-2001 |
|
/ |
Unkown |
HY-15097S |
Myricetin-13C3 |
Inducer |
/ |
Unkown |
HY-153456 |
Hedgehog IN-2 |
Inhibitor |
/ |
Unkown |
HY-15398S1 |
Vitamin D3-13C3 |
Activator |
/ |
Unkown |
HY-155259 |
Pomalidomide-5-C3-NH2 hydrochloride |
|
96.02% |
Unkown |
HY-155502 |
AKR1C3-IN-10 |
Inhibitor |
/ |
Unkown |
HY-155716 |
G43-C3-TEG |
Inhibitor |
/ |
Unkown |
HY-157510 |
Thalidomide-O-C3-azide |
|
/ |
Unkown |
HY-157810 |
AKR1C3-IN-11 |
Inhibitor |
/ |
Unkown |
HY-158383 |
Pomalidomide-CO-C3-PEG4-C6-NH2 |
|
/ |
Unkown |
HY-158732 |
MAO-B-IN-33 |
Inhibitor |
/ |
Unkown |
HY-159604 |
METTL3-IN-9 |
Inhibitor |
/ |
Unkown |
HY-15977 |
(S)-P7C3-OMe |
|
/ |
Unkown |
HY-161131 |
Lenalidomide 4'-alkyl-C3-azide |
|
/ |
Unkown |
HY-161468 |
Thalidomide-N-C3-O-C4-O-C3-OH |
Inducer |
/ |
Unkown |
HY-161653 |
Boc-NH-C3-O-Ph(NO2)-methylester-O-pyrrolidine-2,5-dione |
|
/ |
Unkown |
HY-161708 |
PROTAC FLT3/CDKs degrader-1 |
Degrader |
/ |
Unkown |
HY-161832 |
(S,R,S)-Me-AHPC-amide-C3-alkyne |
|
/ |
Unkown |
HY-161839 |
AKR1C2/3-IN-1 |
Inhibitor |
/ |
Unkown |
HY-161929 |
GPX4 activator 2 |
|
/ |
Unkown |
HY-162714 |
C3N-Dbn-Trp2 |
Inhibitor |
/ |
Unkown |
HY-162816 |
PROTAC HPK1 Degrader-3 |
|
/ |
Unkown |
HY-163223 |
(S,R,S)-AHPC-CO-CH2-piperazine-C3-piperazine-Boc |
|
/ |
Unkown |
HY-163267 |
ZNL0325 |
|
/ |
Unkown |
HY-163323 |
AKR1C3-IN-12 |
Inhibitor |
/ |
Unkown |
HY-163609 |
PROTAC AKR1C3 degrader-1 |
Degrader |
/ |
Unkown |
HY-163610 |
AKR1C3-IN-13 |
Inhibitor |
/ |
Unkown |
HY-163678 |
Pomalidomide-CO-C7-NH-CO-C3-COOH |
|
/ |
Unkown |
HY-163758 |
COOH-C3-CONH-C7-COOH |
|
/ |
Unkown |
HY-163784 |
AKR1C3-IN-14 |
Inhibitor |
/ |
Unkown |
HY-163821 |
HO-CONH-C3-PEG3-NH2 |
|
/ |
Unkown |
HY-163903 |
OH-C2-PEG3-NHCO-C3-COOH |
|
/ |
Unkown |
HY-163904 |
(S,R,R)-VH032-CO-C3-CONH-C2-PEG3-OH |
|
/ |
Unkown |
HY-163940 |
LX1 |
Inhibitor |
/ |
Unkown |
HY-163962 |
L18I |
|
/ |
Unkown |
HY-163964 |
Lenalidomide-C3-PEG3-N3 |
|
/ |
Unkown |
HY-164085 |
Azide-C3-NHCO-C3-NHS ester |
|
/ |
Unkown |
HY-17461S |
Cortisone-13C3 |
Agonist |
/ |
Unkown |
HY-18085S2 |
Quercetin-13C3 |
|
/ |
Unkown |
HY-19717S |
DCVC-13C3,15N |
|
/ |
Unkown |
HY-23506S |
1-Aminoimidazolidine-2,4-dione-13C3 |
|
/ |
Unkown |
HY-32351B |
3-epi-Calcifediol |
|
/ |
Unkown |
HY-A0090S |
Nitrofurantoin-13C3 |
|
/ |
Unkown |
HY-A0132S5 |
N-Acetyl-D-glucosamine-13C-3 |
|
/ |
Unkown |
HY-A0132S9 |
N-Acetyl-D-glucosamine-13C3,15N |
|
/ |
Unkown |
HY-A0253S |
Cefacetrile-13C3 |
|
/ |
Unkown |
HY-B0143S4 |
Niacin-15N,13C3 |
|
/ |
Unkown |
HY-B0150S1 |
Nicotinamide-15N,13C3 |
Inhibitor |
/ |
Unkown |
HY-B0166S4 |
L-Ascorbic acid-13C-3 |
|
/ |
Unkown |
HY-B0234S |
Estrone-13C3 |
Agonist |
/ |
Unkown |
HY-B0388S |
Probucol-13C3 |
Inhibitor |
/ |
Unkown |
HY-B0389S13 |
D-Glucose-13C-3 |
|
/ |
Unkown |
HY-B0389S18 |
D-Glucose-13C3-1 |
|
/ |
Unkown |
HY-B0389S9 |
D-Glucose-13C3-2 |
|
/ |
Unkown |
HY-B0412S3 |
Estriol-13C3 |
Antagonist |
/ |
Unkown |
HY-B0430S |
Pantothenic acid-13C3,15N hemicalcium |
|
/ |
Unkown |
HY-B0495S |
Lamotrigine-13C3,d3 |
|
/ |
Unkown |
HY-B0495S4 |
Lamotrigine-13C3 |
|
/ |
Unkown |
HY-B0510S3 |
Trimethoprim-13C3 |
|
/ |
Unkown |
HY-B0526S |
Flumequine-13C3 |
Inhibitor |
/ |
Unkown |
HY-B0891S1 |
17α-Hydroxyprogesterone-13C3 |
Agonist |
/ |
Unkown |
HY-B1075AS |
(Rac)-Fosfomycin (benzylamine)-13C3 |
|
/ |
Unkown |
HY-B1241A |
Dihydrostreptomycin |
|
/ |
Unkown |
HY-B1331S1 |
Cyromazine-13C3 |
|
/ |
Unkown |
HY-B1449S4 |
Uridine-13C-3 |
|
/ |
Unkown |
HY-B1659S |
Glycerol-13C3,d8 |
|
/ |
Unkown |
HY-D1516 |
NerveGreen C3 |
|
/ |
Unkown |
HY-D1558 |
1,3,5,7-Tetramethyl-2,6-diiodo-C3-SE-BODIPYs |
|
/ |
Unkown |
HY-D1581 |
BODIPY 505/515-8-C3-COOH |
|
/ |
Unkown |
HY-D2200 |
Cy5.5(Me)-C3-DBCO |
|
/ |
Unkown |
HY-I0400S3 |
N-Acetylneuraminic acid-13C-3 |
|
/ |
Unkown |
HY-N0001S |
(±)-Epicatechin-13C3 |
|
/ |
Unkown |
HY-N0055S |
Chlorogenic acid-13C3 |
|
/ |
Unkown |
HY-N0059S3 |
D-Arabinose-13C-3 |
|
/ |
Unkown |
HY-N0060S1 |
Ferulic acid-13C3 |
Inhibitor |
/ |
Unkown |
HY-N0086S3 |
N6-Methyladenosine-13C3 |
Inhibitor |
/ |
Unkown |
HY-N0172S |
Caffeic acid-13C3 |
Inhibitor |
/ |
Unkown |
HY-N0210S2 |
D-Galactose-13C-3 |
|
/ |
Unkown |
HY-N0229S10 |
L-Alanine-13C3,15N |
|
≥98.0% |
Unkown |
HY-N0229S5 |
L-Alanine-13C3,15N,d4 |
|
/ |
Unkown |
HY-N0229S8 |
L-Alanine-13C3 |
|
/ |
Unkown |
HY-N0230S |
β-Alanine-13C3,15N |
|
/ |
Unkown |
HY-N0351S |
p-Coumaric acid-13C3 |
|
/ |
Unkown |
HY-N0356S |
(+/-)-Catechin Gallate-13C3 |
Inhibitor |
/ |
Unkown |
HY-N0379S8 |
D-Mannose-13C-3 |
|
/ |
Unkown |
HY-N0382S |
Galangin-13C3 |
|
/ |
Unkown |
HY-N0464S |
Quinic acid-13C3 |
|
/ |
Unkown |
HY-N0521AS |
(+)-Gallocatechin-13C3 |
|
/ |
Unkown |
HY-N0610AS2 |
Cinnamic acid-13C3 |
|
99.91% |
Unkown |
HY-N0650S3 |
L-Serine-13C3,15N,d3 |
|
/ |
Unkown |
HY-N0683S1 |
α-Vitamin E-13C3 |
Inhibitor |
/ |
Unkown |
HY-N0771S6 |
L-Cysteine-13C3,15N,d3 |
|
/ |
Unkown |
HY-N10263 |
Palmarumycin C3 |
|
/ |
Unkown |
HY-N10519 |
Cellooctaose |
|
/ |
Unkown |
HY-N10998 |
Chamaejasmenin A |
|
/ |
Unkown |
HY-N11646 |
Ganorbiformin B |
Inhibitor |
/ |
Unkown |
HY-N1428S3 |
Citric acid-13C3 |
|
/ |
Unkown |
HY-N1480S3 |
(-)-Fucose-13C-3 |
|
/ |
Unkown |
HY-N2041S4 |
Myristic acid-13C3 |
|
/ |
Unkown |
HY-N3205 |
Neochamaejasmin B |
|
/ |
Unkown |
HY-N7091S1 |
Atrazine-13C3,15N3 |
|
/ |
Unkown |
HY-N8847S |
α-Ionone-13C3 |
|
/ |
Unkown |
HY-N9332 |
Kalopanax saponin G |
|
/ |
Unkown |
HY-P1142S |
GLP-2(rat) (Ala-13C3,15N) |
|
/ |
Unkown |
HY-P1142S1 |
GLP-2(rat) (Ala-13C3,15N) (TFA) |
|
/ |
Unkown |
HY-P1345 |
TLQP-21 |
Agonist |
/ |
Unkown |
HY-P1505 |
C3a (70-77) |
|
/ |
Unkown |
HY-P1640 |
(Trp63,Trp64)-C3a(63-77) |
Agonist |
/ |
Unkown |
HY-P2325 |
Exoenzyme C3, clostridium botulinum |
|
/ |
Unkown |
HY-P5071 |
EcAMP3 |
|
/ |
Unkown |
HY-R00006A |
hsa-let-7c-3p agomir |
|
/ |
Unkown |
HY-R00333 |
hsa-miR-181c-3p mimic |
|
/ |
Unkown |
HY-R00333A |
hsa-miR-181c-3p agomir |
|
/ |
Unkown |
HY-R00407 |
hsa-miR-200c-3p mimic |
|
/ |
Unkown |
HY-R00407A |
hsa-miR-200c-3p agomir |
|
/ |
Unkown |
HY-R00717A |
hsa-miR-34c-3p agomir |
|
/ |
Unkown |
HY-R00832 |
hsa-miR-374c-3p mimic |
|
/ |
Unkown |
HY-R00832A |
hsa-miR-374c-3p agomir |
|
/ |
Unkown |
HY-R00840A |
hsa-miR-376c-3p agomir |
|
/ |
Unkown |
HY-R01112 |
hsa-miR-449c-3p mimic |
|
/ |
Unkown |
HY-R01112A |
hsa-miR-449c-3p agomir |
|
/ |
Unkown |
HY-R01546 |
hsa-miR-513c-3p mimic |
|
/ |
Unkown |
HY-R01546A |
hsa-miR-513c-3p agomir |
|
/ |
Unkown |
HY-R01568A |
hsa-miR-518c-3p agomir |
|
/ |
Unkown |
HY-R01590 |
hsa-miR-519c-3p mimic |
|
/ |
Unkown |
HY-R01590A |
hsa-miR-519c-3p agomir |
|
/ |
Unkown |
HY-R01598 |
hsa-miR-520c-3p mimic |
|
/ |
Unkown |
HY-R01598A |
hsa-miR-520c-3p agomir |
|
/ |
Unkown |
HY-R01678A |
hsa-miR-548c-3p agomir |
|
/ |
Unkown |
HY-R02506 |
hsa-miR-892c-3p mimic |
|
/ |
Unkown |
HY-R02506A |
hsa-miR-892c-3p agomir |
|
/ |
Unkown |
HY-R02698 |
mmu-miR-181c-3p mimic |
|
/ |
Unkown |
HY-R02698A |
mmu-miR-181c-3p agomir |
|
/ |
Unkown |
HY-R02795 |
mmu-miR-1970c-3p mimic |
|
/ |
Unkown |
HY-R02795A |
mmu-miR-1970c-3p agomir |
|
/ |
Unkown |
HY-R02833 |
mmu-miR-216c-3p mimic |
|
/ |
Unkown |
HY-R02833A |
mmu-miR-216c-3p agomir |
|
/ |
Unkown |
HY-R02840 |
mmu-miR-219c-3p mimic |
|
/ |
Unkown |
HY-R02840A |
mmu-miR-219c-3p agomir |
|
/ |
Unkown |
HY-R02897 |
mmu-miR-302c-3p mimic |
|
/ |
Unkown |
HY-R02897A |
mmu-miR-302c-3p agomir |
|
/ |
Unkown |
HY-R03043 |
mmu-miR-344c-3p mimic |
|
/ |
Unkown |
HY-R03043A |
mmu-miR-344c-3p agomir |
|
/ |
Unkown |
HY-R03077 |
mmu-miR-34c-3p mimic |
|
/ |
Unkown |
HY-R03077A |
mmu-miR-34c-3p agomir |
|
/ |
Unkown |
HY-R03104 |
mmu-miR-374c-3p mimic |
|
/ |
Unkown |
HY-R03104A |
mmu-miR-374c-3p agomir |
|
/ |
Unkown |
HY-R03111 |
mmu-miR-376c-3p mimic |
|
/ |
Unkown |
HY-R03111A |
mmu-miR-376c-3p agomir |
|
/ |
Unkown |
HY-R03148 |
mmu-miR-449c-3p mimic |
|
/ |
Unkown |
HY-R03148A |
mmu-miR-449c-3p agomir |
|
/ |
Unkown |
HY-R03198 |
mmu-miR-467c-3p mimic |
|
/ |
Unkown |
HY-R03198A |
mmu-miR-467c-3p agomir |
|
/ |
Unkown |
HY-R03460 |
mmu-miR-669c-3p mimic |
|
/ |
Unkown |
HY-R03460A |
mmu-miR-669c-3p agomir |
|
/ |
Unkown |
HY-R04277 |
rno-miR-196c-3p mimic |
|
/ |
Unkown |
HY-R04277A |
rno-miR-196c-3p agomir |
|
/ |
Unkown |
HY-R04284 |
rno-miR-200c-3p mimic |
|
/ |
Unkown |
HY-R04284A |
rno-miR-200c-3p agomir |
|
/ |
Unkown |
HY-R04468 |
rno-miR-449c-3p mimic |
|
/ |
Unkown |
HY-R04468A |
rno-miR-449c-3p agomir |
|
/ |
Unkown |
HY-R04484 |
rno-miR-466c-3p mimic |
|
/ |
Unkown |
HY-R04484A |
rno-miR-466c-3p agomir |
|
/ |
Unkown |
HY-RI00006 |
hsa-let-7c-3p inhibitor |
|
/ |
Unkown |
HY-RI00006A |
hsa-let-7c-3p antagomir |
|
/ |
Unkown |
HY-RI00333 |
hsa-miR-181c-3p inhibitor |
|
/ |
Unkown |
HY-RI00333A |
hsa-miR-181c-3p antagomir |
|
/ |
Unkown |
HY-RI00407A |
hsa-miR-200c-3p antagomir |
|
/ |
Unkown |
HY-RI00717 |
hsa-miR-34c-3p inhibitor |
|
/ |
Unkown |
HY-RI00717A |
hsa-miR-34c-3p antagomir |
|
/ |
Unkown |
HY-RI00832 |
hsa-miR-374c-3p inhibitor |
|
/ |
Unkown |
HY-RI00832A |
hsa-miR-374c-3p antagomir |
|
/ |
Unkown |
HY-RI00840A |
hsa-miR-376c-3p antagomir |
|
/ |
Unkown |
HY-RI01112 |
hsa-miR-449c-3p inhibitor |
|
/ |
Unkown |
HY-RI01112A |
hsa-miR-449c-3p antagomir |
|
/ |
Unkown |
HY-RI01546 |
hsa-miR-513c-3p inhibitor |
|
/ |
Unkown |
HY-RI01546A |
hsa-miR-513c-3p antagomir |
|
/ |
Unkown |
HY-RI01568 |
hsa-miR-518c-3p inhibitor |
|
/ |
Unkown |
HY-RI01568A |
hsa-miR-518c-3p antagomir |
|
/ |
Unkown |
HY-RI01590 |
hsa-miR-519c-3p inhibitor |
|
/ |
Unkown |
HY-RI01590A |
hsa-miR-519c-3p antagomir |
|
/ |
Unkown |
HY-RI01598 |
hsa-miR-520c-3p inhibitor |
|
/ |
Unkown |
HY-RI01598A |
hsa-miR-520c-3p antagomir |
|
/ |
Unkown |
HY-RI01678 |
hsa-miR-548c-3p inhibitor |
|
/ |
Unkown |
HY-RI01678A |
hsa-miR-548c-3p antagomir |
|
/ |
Unkown |
HY-RI02506 |
hsa-miR-892c-3p inhibitor |
|
/ |
Unkown |
HY-RI02506A |
hsa-miR-892c-3p antagomir |
|
/ |
Unkown |
HY-RI02698 |
mmu-miR-181c-3p inhibitor |
|
/ |
Unkown |
HY-RI02698A |
mmu-miR-181c-3p antagomir |
|
/ |
Unkown |
HY-RI02795 |
mmu-miR-1970c-3p inhibitor |
|
/ |
Unkown |
HY-RI02795A |
mmu-miR-1970c-3p antagomir |
|
/ |
Unkown |
HY-RI02833 |
mmu-miR-216c-3p inhibitor |
|
/ |
Unkown |
HY-RI02833A |
mmu-miR-216c-3p antagomir |
|
/ |
Unkown |
HY-RI02840 |
mmu-miR-219c-3p inhibitor |
|
/ |
Unkown |
HY-RI02840A |
mmu-miR-219c-3p antagomir |
|
/ |
Unkown |
HY-RI02897 |
mmu-miR-302c-3p inhibitor |
|
/ |
Unkown |
HY-RI02897A |
mmu-miR-302c-3p antagomir |
|
/ |
Unkown |
HY-RI03043 |
mmu-miR-344c-3p inhibitor |
|
/ |
Unkown |
HY-RI03043A |
mmu-miR-344c-3p antagomir |
|
/ |
Unkown |
HY-RI03077 |
mmu-miR-34c-3p inhibitor |
|
/ |
Unkown |
HY-RI03077A |
mmu-miR-34c-3p antagomir |
|
/ |
Unkown |
HY-RI03104 |
mmu-miR-374c-3p inhibitor |
|
/ |
Unkown |
HY-RI03104A |
mmu-miR-374c-3p antagomir |
|
/ |
Unkown |
HY-RI03111 |
mmu-miR-376c-3p inhibitor |
|
/ |
Unkown |
HY-RI03111A |
mmu-miR-376c-3p antagomir |
|
/ |
Unkown |
HY-RI03148 |
mmu-miR-449c-3p inhibitor |
|
/ |
Unkown |
HY-RI03148A |
mmu-miR-449c-3p antagomir |
|
/ |
Unkown |
HY-RI03198 |
mmu-miR-467c-3p inhibitor |
|
/ |
Unkown |
HY-RI03198A |
mmu-miR-467c-3p antagomir |
|
/ |
Unkown |
HY-RI03460 |
mmu-miR-669c-3p inhibitor |
|
/ |
Unkown |
HY-RI03460A |
mmu-miR-669c-3p antagomir |
|
/ |
Unkown |
HY-RI04277 |
rno-miR-196c-3p inhibitor |
|
/ |
Unkown |
HY-RI04277A |
rno-miR-196c-3p antagomir |
|
/ |
Unkown |
HY-RI04284 |
rno-miR-200c-3p inhibitor |
|
/ |
Unkown |
HY-RI04284A |
rno-miR-200c-3p antagomir |
|
/ |
Unkown |
HY-RI04468 |
rno-miR-449c-3p inhibitor |
|
/ |
Unkown |
HY-RI04468A |
rno-miR-449c-3p antagomir |
|
/ |
Unkown |
HY-RI04484 |
rno-miR-466c-3p inhibitor |
|
/ |
Unkown |
HY-RI04484A |
rno-miR-466c-3p antagomir |
|
/ |
Unkown |
HY-RS00536 |
AKR1C3 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS01743 |
C3 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS01744 |
C3AR1 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS05969 |
H3C3 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS05976 |
H4C3 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS10520 |
PIK3C3 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS10521 |
Pik3c3 Mouse Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS10522 |
Pik3c3 Rat Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-W007376S |
Indole-3-carboxaldehyde-13C |
|
/ |
Unkown |
HY-W007798S |
Fmoc-Cys(Trt)-OH-1,2,3-13C3,15N |
|
/ |
Unkown |
HY-W007941S |
Fmoc-Ser(tBu)-OH-13C3,15N |
|
/ |
Unkown |
HY-W009204S4 |
Fmoc-Ala-OH-13C3,15N |
|
/ |
Unkown |
HY-W009204S5 |
Fmoc-Ala-OH-13C3 |
Modulator |
/ |
Unkown |
HY-W010407S2 |
Cyanuric acid-13C3,15N3 |
|
/ |
Unkown |
HY-W010575S |
(2R)-3-Amino-2-fluoropropanoic acid-13C3 |
|
/ |
Unkown |
HY-W013061S1 |
Propane-1,2,3-triyl tripalmitate-13C3 |
|
/ |
Unkown |
HY-W013061S4 |
Propane-1,2,3-triyl tripalmitate-13C3-1 |
|
/ |
Unkown |
HY-W015084S |
β-Ionone-13C3 |
Inducer |
/ |
Unkown |
HY-W017529S |
6-Chloro-1,3,5-triazine-2,4-diamine-13C3 |
|
/ |
Unkown |
HY-W018772S4 |
D-Ribose-13C-3 |
|
/ |
Unkown |
HY-W020044S |
DL-alpha-Tocopherol-13C3 |
Inhibitor |
/ |
Unkown |
HY-W091039S |
N-Acetyl-α-neuraminic acid-13C3 |
|
/ |
Unkown |
HY-W096151 |
Chloroacetamido-C-PEG3-C3-NHBoc |
|
/ |
Unkown |
HY-W099927 |
[C3MPr]NTf2 |
|
/ |
Unkown |
HY-W127393 |
N-Nonanoyl-L-homoserine lactone |
|
/ |
Unkown |
HY-W127487 |
N-Octadecanoyl-L-homoserine lactone |
|
/ |
Unkown |
HY-W269693S |
5-(4-Hydroxyphenyl)-5-phenylimidazolidine-2,4-dione-d5,13C3 |
|
/ |
Unkown |
HY-W324220 |
11β-HSD1-IN-10 |
|
/ |
Unkown |
HY-W357090S |
L-Idose-13C-3 |
|
/ |
Unkown |
HY-W584535 |
VH032-C3-Boc |
|
/ |
Unkown |
HY-W653989 |
Desonide-13C3 |
|
/ |
Unkown |
HY-W753983 |
Pyruvic acid-13C3 |
|
/ |
Unkown |
HY-Y0418S3 |
Dulcite-13C-3 |
|
/ |
Unkown |
HY-Y0504S |
Trimethylammonium chloride-13c3,d9 |
|
/ |
Unkown |
HY-Y0921S3 |
(±)-1,2-Propanediol-13C3 |
|
/ |
Unkown |
HY-Y1117S1 |
Melamine-13C3 |
|
/ |
Unkown |
HY-Y1117S2 |
Melamine-15N3,13C3 |
|
/ |
Unkown |
HY-Y1662 |
D-Aminoacylase |
|
/ |
Unkown |
HY-10002S |
Calcitriol-13C3 |
Inhibitor |
≥97.0% |
Unkown |
HY-100840 |
(S)-4C3HPG |
|
/ |
Unkown |
HY-100840A |
(RS)-4C3HPG |
Antagonist |
/ |
Unkown |
HY-105414 |
Esterbut-3 |
|
/ |
Unkown |
HY-105969 |
Dichloromethotrexate |
|
/ |
Unkown |
HY-113294S |
3-Hydroxykynurenine-13C3,15N |
|
98.74% |
Unkown |
HY-116170 |
SN34037 |
|
/ |
Unkown |
HY-118645S1 |
1'-Hydroxymidazolam-13C3 |
|
/ |
Unkown |
HY-121656 |
AKR1C2/3-IN-2 |
|
/ |
Unkown |
HY-122585 |
proMMP-9 inhibitor-3c |
Inhibitor |
/ |
Unkown |
HY-137225 |
HTS07944 |
|
/ |
Unkown |
HY-139227 |
Thalidomide 4'-oxyacetamide-C1-PEG3-C3-amine hydrochloride |
Inducer |
/ |
Unkown |
HY-144344S |
Benzyl(2R)-3-N,N-dibenzylamino-2-fluoropropanoate-13C3 |
|
/ |
Unkown |
HY-149560 |
Thalidomide-5-O-C3-NH2 hydrochloride |
|
99.08% |
Unkown |
HY-150532S |
(Rac)-Vitamin B5,Calcium Salt Hydrate-13C3 15N |
|
/ |
Unkown |
HY-151997S |
1,2-Dioleoyl-3-lauroyl-rac-glycerol-13C3 |
|
/ |
Unkown |
HY-153539 |
AP-C3 |
Inhibitor |
/ |
Unkown |
HY-153540 |
AP-C4 |
Inhibitor |
/ |
Unkown |
HY-154746S |
3-HPMA Potassium Salt-3-13C3,15N |
|
/ |
Unkown |
HY-154814S |
Monohydroxy-3-butenyl-mercapturic acid-13C3,15N sodium |
|
/ |
Unkown |
HY-158861 |
C3-K2-E14 |
|
/ |
Unkown |
HY-158994S |
MEGDSRGG-(Ala-13C3,15N)-GGEA-(Leu-13C6,15N)-DPESAASSLSGAS TFA |
|
/ |
Unkown |
HY-159145 |
Lenalidomide-acetylene-C3-MsO |
|
/ |
Unkown |
HY-161652 |
Thalidomide-NH-C3-O-Ph(NO2)-methylester-O-pyrrolidine-2,5-dione |
|
/ |
Unkown |
HY-161656 |
PIP-C-3-Azaspiro[5.5]undecane-boc |
|
/ |
Unkown |
HY-163032 |
FABP4-IN-3 |
Inhibitor |
/ |
Unkown |
HY-163647 |
Lenalidomide-COCH-PEG2-azido |
|
/ |
Unkown |
HY-168192 |
Thalidomide-NH-C4-amide-C3-Br |
|
/ |
Unkown |
HY-B0111RS |
Drospirenone-13C3 |
|
/ |
Unkown |
HY-B1804S |
Tricaprilin-13C3 |
|
/ |
Unkown |
HY-N0092S4 |
Inosine-13C3 |
|
/ |
Unkown |
HY-N0368S1 |
Linalool-13C3 |
|
/ |
Unkown |
HY-N0803S1 |
Myrcene-13C3 |
Inhibitor |
/ |
Unkown |
HY-N1071 |
Wilforol C |
|
/ |
Unkown |
HY-N12816 |
Glaucogenin C 3-O-α-L-cymaropyranosyl-(1→4)–β-D-digitoxopyranosyl-(1→4)-β-D-canaropyranoside |
|
/ |
Unkown |
HY-N1849 |
3'-Methoxyrocaglamide |
|
/ |
Unkown |
HY-N2355 |
Solasurine |
|
/ |
Unkown |
HY-N7092S22 |
D-Fructose-13C3 |
|
/ |
Unkown |
HY-N7092S23 |
D-Fructose-13C3-1 |
|
/ |
Unkown |
HY-N9522 |
β-D-glucopyranosyl-[α-L-rhamnopyranosyl-(1→3)-βD-glucuronopyranosyl-(1→3)]-3β-hydroxyolean-12-ene28-oate |
|
99.95% |
Unkown |
HY-W012578S1 |
2-Isopropyl-3-methoxypyrazine-13C3 |
|
/ |
Unkown |
HY-W012932S |
2,4-Dimethylthiazole-13C3 |
|
/ |
Unkown |
HY-W046063 |
O-Phthalimide-C3-acid |
|
/ |
Unkown |
HY-W156840S |
OTNE-13C3 |
|
/ |
Unkown |
HY-W585905 |
Trimethylammonium chloride-13C3 |
|
/ |
Unkown |
HY-W585956 |
Triclocarban-13C6 |
|
/ |
Unkown |
HY-W654120 |
Creatine-13C3 |
|
/ |
Unkown |
HY-W654362 |
(R)-2-Thioxothiazolidine-4-carboxylic acid-13C3 |
|
/ |
Unkown |
HY-W751098 |
Aldosterone-13C3 |
|
/ |
Unkown |
HY-W751099 |
Corticosterone-13C3 |
|
/ |
Unkown |
HY-W769714 |
Favipiravir-13C3 |
Inhibitor |
/ |
Unkown |
HY-W770183 |
Uric acid-13C3 |
|
/ |
Unkown |